Education
About Us
Working with TipRanks
Follow Us
Crescent Biopharma (CBIO)
NASDAQ:CBIO
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 10.00K | $ 75.00K | $ 1.16M |
| Gross Profit | $ 0.00 | $ -35.17K | $ 10.00K | $ 75.00K | $ 1.16M |
| Operating Income | $ -152.63M | $ -68.76M | $ -39.28M | $ -47.40M | $ -63.45M |
| EBITDA | $ -152.63M | $ 0.00 | $ -39.12M | $ -47.20M | $ -63.18M |
| Net Income | $ -149.94M | $ -71.47M | $ -36.90M | $ -46.69M | $ -63.43M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 213.19M | $ 34.77M | $ 41.79M | $ 47.87M | $ 90.25M |
| Total Assets | $ 240.29M | $ 35.62M | $ 45.32M | $ 51.81M | $ 94.35M |
| Total Debt | $ 1.64M | $ 37.48M | $ 808.40K | $ 918.55K | $ 1.92M |
| Net Debt | $ -211.55M | $ 2.72M | $ -40.98M | $ -46.95M | $ -88.33M |
| Total Liabilities | $ 37.28M | $ 51.10M | $ 6.90M | $ 8.88M | $ 12.74M |
| Stockholders' Equity | $ 203.01M | $ 5.31M | $ 38.41M | $ 42.93M | $ 81.60M |
| Cash Flow | |||||
| Free Cash Flow | $ -72.45M | $ -31.11M | $ -34.90M | $ -46.54M | $ -57.50M |
| Operating Cash Flow | $ -71.53M | $ -31.10M | $ -34.88M | $ -46.46M | $ -57.49M |
| Investing Cash Flow | $ -72.92M | $ 20.03K | $ -21.39K | $ -84.19K | $ -14.94K |
| Financing Cash Flow | $ 322.98M | $ 5.40K | $ 28.82M | $ 4.16M | $ 10.72M |